Key Developments: Vitrolife AB (VITRO.F)

VITRO.F on Frankfurt Stock Exchange

13.06EUR
11 Jul 2014
Price Change (% chg)

€0.69 (+5.60%)
Prev Close
€12.37
Open
€13.00
Day's High
€13.06
Day's Low
€13.00
Volume
500
Avg. Vol
221
52-wk High
€14.40
52-wk Low
€7.39

Search Stocks

Latest Key Developments (Source: Significant Developments)

Vitrolife AB announces details on FY 2013 dividend and elects Deloitte AB as auditor
Tuesday, 6 May 2014 02:30am EDT 

Vitrolife AB:Says board’s proposed dividend of 1.00 Swedish crown per share for the financial year 2013 was approved by annual general meeting.May 8 was adopted as record day.Says annual general meeting elected Deloitte AB, with authorized public accountant Jan Nilsson as head auditor, and authorized public accountant Fredrik Jonsson as auditors for a term of three years.  Full Article

Vitrolife AB proposes FY 2013 dividend of 1.00 Swedish crown per share
Thursday, 6 Feb 2014 02:30am EST 

Vitrolife AB:Says its Board proposes a dividend of 1.00 Swedish crown per share for fiscal year 2013.Says it paid a dividend of 0.60 Swedish crown per share for fiscal year 2012.  Full Article

Vitrolife AB and Biolamina AB Extend Collaboration; Vitrolife Acquires Stake in Biolamina
Wednesday, 13 Nov 2013 02:30am EST 

Vitrolife AB announced that it has collaborated with the Stockholm-based Biolamina AB within the stem-cell field since 2012. The companies have decided to extend their collaboration and Vitrolife has invested in Biolamina together with the company’s present owners. During spring the collaboration resulted in the launch of a new freeze medium for stem cells, FREEZEstem, which has been developed and produced by Vitrolife and is marketed globally by Biolamina. The companies have decided to extend their collaboration and Vitrolife has invested SEK 4 million in Biolamina in a directed new share issue, which gives Vitrolife a 4.6% participation in the company. Vitrolife takes possession of the shares in Biolamina as soon as the share issue has been registered at the Swedish Companies Registration Office. The investment is financed through Vitrolife’s cash reserves. Vitrolife will also be represented on the company’s Board in the future.  Full Article

Vitrolife AB Appoints Carsten Browall as Chairman
Tuesday, 30 Apr 2013 02:30am EDT 

Vitrolife AB announced that during the Company's Annual General Meeting, Carsten Browall was elected the new Chairman of the Board.  Full Article

Vitrolife AB Acquires Remaining Shares in HertArt ApS
Tuesday, 2 Apr 2013 03:00am EDT 

Vitrolife AB announced that in 2010, it entered into a collaboration agreement with the Danish company HertArt ApS with the aim of developing a new range of disposable plastic products for IVF called Labware. Vitrolife acquired 25% of the shares in HertArt as part of the collaboration agreement. Vitrolife has now exercised an option to acquire all the shares in the company. HertArt has developed and registered a portfolio of products for IVF such as cultivation dishes, test tubes and pipettes. Vitrolife plans to launch the product range in 2013. The purchase sum amounted to DKK 2 million and may be increased to DKK 3 million if certain defined sales objectives are achieved. The initial purchase sum of DKK 2 million is to be paid in cash and financed from Vitrolife’s cash in hand. It is estimated that the acquisition will only entail a marginal impact on Vitrolife’s earnings per share for 2013.  Full Article

Vitrolife AB Announces Details on FY 2012 Dividend
Tuesday, 26 Mar 2013 03:30am EDT 

Vitrolife AB announced that its Board proposes a dividend of SEK 0.60 per share for fiscal year 2012 and May 3, 2013 as the record date, which means that the last day of trading of shares including dividend is April 29, 2013. It is expected that the dividend will be delivered to shareholders on May 8, 2013.  Full Article

Vitrolife AB's Chairman Patrik Tigerschiold to Step Down
Monday, 25 Mar 2013 11:30am EDT 

Vitrolife AB announced that Patrik Tigerschiold, Chairman of the Board of Directors of the Company, has declined re-election at the Annual General Meeting of the Company to be held on April 19, 2013.  Full Article

Vitrolife AB Proposes FY 2012 Dividend of SEK 0.60 per Share
Thursday, 7 Feb 2013 02:30am EST 

Vitrolife AB announced that its Board proposes fiscal year 2012 dividend of SEK 0.60 per share. For fiscal year 2011, the Company also paid a dividend of SEK 0.60 per share.  Full Article

Swedish Tax Agency Announces Decision on Allotment of Acquisition Cost in Vitrolife AB 's Distribution of Xvivo Perfusion AB's Shares
Thursday, 20 Dec 2012 09:00am EST 

Vitrolife AB announced that in connection with Vitrolife’s distribution of the shares in Xvivo Perfusion AB, the Swedish Tax Agency has decided that 77% of the acquisition cost should be allotted to Vitrolife AB and 23% to Xvivo Perfusion AB.  Full Article

Vitrolife AB Announces Private Placement Fully Subscribed
Wednesday, 31 Oct 2012 12:00pm EDT 

Vitrolife AB (Vitrolife) announced that The Extraordinary General Meeting of Vitrolife held September 24, 2012 adopted a resolution regarding a private placement of EUR 1.352.315 in order to partly finance the acquisition of Cryo Management Ltd (Cryo). It was decided that the new shares were to be issued at a subscription price per share corresponding to the average closing price for Vitrolife's shares during the 15 trading days immediately subsequent to the Vitrolife’s shares being traded exclusive of entitlement to distribution of shares in Xvivo Perfusion AB, based on an average EUR/SEK exchange rate during the aforesaid 15 trading days. The Board of Directors has resolved to determine that the Company’s share capital shall be increased with not more than SEK 273.530,34 by an issue of not more than 268,167 shares and that the subscription price for each share shall be EUR 5.0428 based on an average closing price of 43,29 and an average EUR/SEK exchange rate of 8,5852. The new share issue was fully subscribed for. Payment for the new shares was made by way of set-off of claims that the subscribers had on Vitrolife. The new issued shares are estimated to be registered at Euroclear Sweden AB during November 2012. After the new share issue is finalized, the total number of shares in Vitrolife AB is estimated to 19.830.936.  Full Article

Search Stocks